{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:54:33Z","timestamp":1790834073201,"version":"4.1.0"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The estimated number of cancer cases in India for the year 2022 was found to be 14,61,427. The development of chemotherapeutic agents has reduced the mortality rate, however,they have high toxicity which is a disadvantage. Many researchers have found out that quinolin-2-one possesses anticancer activity, with this background we thought of synthesizing the quinolin-2-one derivatives.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to carry out docking, synthesis, characterization, and evaluation of 2-(2-(4-Hydroxy-2-oxoquinolin-1(2H)-yl)phenyl\/ substituted phenyl)-3-(phenylamino) thiazolidon-4-one derivatives (IVa-g) as an anticancer agent.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>Diphenylamine and malonic acid treated with phosphoryl chloride gave compound I, which on formylation afforded compound II, which on reaction with various substituted aromatic phenylhydrazine derivatives gave compounds IIIa-g, which on further reaction with thioglycolic acid and anhydrous zinc chloride yielded the compounds IVa-g.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Among all the synthesized novel derivatives, compounds IV a-d showed 50% lysis in the IC50 range of 25-50\u00b5g for the A549 cell line, and compounds IVa, and IVb showed 50% lysis in the IC50 range of 25-50\u00b5g for the MDA-MB cell line. The compound, 3-((4-fluorophenyl)amino)-2-(2-(4-hydroxy-2-oxoquinolin-1(2H)-yl)phenyl)thiazolidin-4-one (IVg) was found to be the most active against both the cell line, A549 and MDA-MB with IC50 value of 0.0298\u00b5mol and 0.0338\u00b5mol respectively. The docking results revealed that the synthesized compounds exhibited well-conserved hydrogen bonding with one or more amino acid residues in the active pocket of EGFR tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlotinib (PDB ID:1M17). Compound IVg showed the highest MolDock score of -137.813 compared to the standard drug Imatinib having a MolDock score of -119.354.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Compound IVg showed the highest MolDock score and was also found to be most potent against both the cell line, A549, and MDA-MB.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163820666230719110932","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T07:04:37Z","timestamp":1689836677000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Docking, Synthesis and Evaluation of 4-hydroxy-1-phenyl-2(1H)-quinolone\nDerivatives as Anticancer Agents"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1983-6150","authenticated-orcid":true,"given":"Chaitali Prabhu","family":"Tendulkar","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, P.E.S\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi,\nPonda-Goa, 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4551-9247","authenticated-orcid":true,"given":"Prachita Gauns","family":"Dessai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, P.E.S\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi,\nPonda-Goa, 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-4286","authenticated-orcid":true,"given":"Shivlingrao","family":"Mamle Desai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, P.E.S\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi,\nPonda-Goa, 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3382-0091","authenticated-orcid":true,"given":"Amrita","family":"Kadam","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, P.E.S\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi,\nPonda-Goa, 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.201072","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA Cancer J Clin  2011,61(2),69-90","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/15701638156661810081510373","volume":"17","author":"Priolkar R.N.S.","year":"2020","unstructured":"Priolkar R.N.S.; Shingade S.; Palkar M.; Desai S.M.; Design, synthesis, and characterization of novel linomide analogues and their evaluation for anticancer activity. Curr Drug Discov Technol  2020,17(2),203-212","journal-title":"Curr Drug Discov Technol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s11030-022-10512-7","volume":"27","author":"Dessai P.G.","year":"2022","unstructured":"Dessai P.G.; Dessai S.P.; Dabholkar R.; Design, synthesis, graph theoretical analysis and molecular modelling studies of novel substituted quinoline analogues as promising anti-breast cancer agents. Mol Divers  2022,27(4),1567-1586","journal-title":"Mol Divers"},{"key":"ref=4","author":"Shaikh K.","year":"2021","unstructured":"Shaikh K.; Krishnan S.; Thanki R.M.;  Artifcial intelligence in breast cancer early detection and diagnosis  2021","journal-title":"Artifcial intelligence in breast cancer early detection and diagnosis"},{"key":"ref=5","first-page":"55","volume":"6","author":"Alfonse M.","year":"2014","unstructured":"Alfonse M.; Aref M.M.; Salem A-B.M.; An ontology-based system for cancer diseases knowledge management. Int J Inf Eng Electron Bus  2014,6(6),55-63","journal-title":"Int J Inf Eng Electron Bus"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/ijmr.ijmr_1821_22","volume":"156","author":"Sathishkumar K.","year":"2022","unstructured":"Sathishkumar K.; Chaturvedi M.; Das P.; Stephen S.; Mathur P.; Cancer incidence estimates for 2022 and projection for 2025: Result from National Cancer Registry Programme, India. Indian J Med Res  2022,156(4 and 5),598-607","journal-title":"Indian J Med Res"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F","volume":"88","author":"Kleihues P.","year":"2000","unstructured":"Kleihues P.; Sobin L.H.; World Health Organization classifcation of tumors. Cancer  2000,88(12),2887","journal-title":"Cancer"},{"key":"ref=8","unstructured":"Cancer. Available From:  https:\/\/www.who.int\/news-room\/factsheets\/detail\/cancer"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1016\/j.arabjc.2016.10.009","volume":"12","author":"Jain S.","year":"2019","unstructured":"Jain S.; Chandra V.; Jain P.K.; Pathak K.; Pathak D.; Vaidya A.; Comprehensive review on current developments of quinoline-based anticancer agents. Arab J Chem  2019,12(8),4920-4946","journal-title":"Arab J Chem"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmech.2012.11.016","volume":"59","author":"Chen I.L.","year":"2013","unstructured":"Chen I.L.; Chen J.J.; Lin Y.C.; Peng C.T.; Juang S.H.; Wang T.C.; Synthesis and antiproliferative activities of N-(napthalen-2-yl) acetamide and N-(substituted phenyl)acetamide bearing quinolin-2(1H)-one and 3,4-dihydroquinolin-2(1H)-one derivatives. Eur J Med Chem  2013,59,227-234","journal-title":"Eur J Med Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2012.08.039","volume":"57","author":"Abonia R.","year":"2012","unstructured":"Abonia R.; Insuasty D.; Castillo J.; Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity. Eur J Med Chem  2012,57,29-40","journal-title":"Eur J Med Chem"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.22159\/ajpcr.2017.v10i8.18836","volume":"10","author":"Bajaj P.","year":"2017","unstructured":"Bajaj P.; Mamle Desai S.; Dighe P.; Naik S.; Biradar B.; Synthesis of 4-hydroxy-3-(1-hydroxy-2-(substitutedamino)ethyl)-1- phenyl\/methylquinolin-2(1H)-one as anticancer agents. Asian J Pharm Clin Res  2017,10,225-228","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=13","first-page":"63","volume":"4","author":"Kharb R.","year":"2013","unstructured":"Kharb R.; Kaur H.; Therapeutic significance of quinoline derivatives as antimicrobial agents. IRJP  2013,4,63-69","journal-title":"IRJP"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1016\/j.bmcl.2012.07.081","volume":"22","author":"Liu H.B.","year":"2012","unstructured":"Liu H.B.; Tang H.; Yang D.; Deng Q.; Yuan L.J.; Ji Q.G.; Synthesis and biological evaluation of novel N-acyl substituted quinolin-2(1H)-one derivatives as potential antimicrobial agents. Bioorg Med Chem Lett  2012,22(18),5845-5848","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmech.2014.05.024","volume":"81","author":"Ferretti M.D.","year":"2014","unstructured":"Ferretti M.D.; Neto A.T.; Morel A.F.; Kaufman T.S.; Larghi E.L.; Synthesis of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4-dihydro-1H-quinolin-2-ones, as novel quinoline derivatives with antibacterial activity. Eur J Med Chem  2014,81,253-266","journal-title":"Eur J Med Chem"},{"key":"ref=16","first-page":"173","volume":"25","author":"Rajadhyax A.","year":"2015","unstructured":"Rajadhyax A.; Mamle Desai S.; Naik S.; Tari P.; Synthesis of 4-methoxy-1-phenyl\/methyl-3-[5-(phenyl\/substitutedphenyl)-4,5- dihydro-(1H)-pyrazol-3-yl]quinolin-2(1H)-one derivatives as antibacterial agents. Indian J Heterocycl Chem  2015,25,173-176","journal-title":"Indian J Heterocycl Chem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bmc.2010.11.045","volume":"19","author":"Curreli F.","year":"2011","unstructured":"Curreli F.; Zhang H.; Zhang X.; Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Bioorg Med Chem  2011,19(1),77-90","journal-title":"Bioorg Med Chem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.3390\/molecules16097649","volume":"16","author":"Cheng P.","year":"2011","unstructured":"Cheng P.; Gu Q.; Liu W.; Synthesis of quinolin-2-one alkaloid derivatives and their inhibitory activities against HIV-1 reverse transcriptase. Molecules  2011,16(9),7649-7661","journal-title":"Molecules"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1016\/j.bmcl.2013.06.051","volume":"23","author":"Sala M.","year":"2013","unstructured":"Sala M.; Chimento A.; Saturnino C.; Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines. Bioorg Med Chem Lett  2013,23(17),4990-4995","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=20","first-page":"1254","volume":"55","author":"Reis M.","year":"2016","unstructured":"Reis M.; Mamle Desai S.; Naik S.; Fernandes J.; Tari P.; Synthesis and evaluation of 2-(4-methoxy-2-oxo-1-phenyl\/methyl-1,2- dihydroquinolin-3-yl)-2-methyl-3-(phenyl\/substituted phenylamino)thiazolidin-4-one as antibacterial and anticancer agents. Indian J Chem Sect B  2016,55,1254-1258","journal-title":"Indian J Chem Sect B"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejmech.2015.02.053","volume":"94","author":"Revelant G.","year":"2015","unstructured":"Revelant G.; Huber-Villaume S.; Dunand S.; Kirsch G.; Schohn H.; Hesse S.; Synthesis and biological evaluation of novel 2-heteroarylimino-1,3-thiazolidin-4-ones as potential anti-tumor agents. Eur J Med Chem  2015,94,102-112","journal-title":"Eur J Med Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2013.04.010","volume":"64","author":"Hu J.","year":"2013","unstructured":"Hu J.; Wang Y.; Wei X.; Synthesis and biological evaluation of novel thiazolidinone derivatives as potential anti-inflammatory agents. Eur J Med Chem  2013,64,292-301","journal-title":"Eur J Med Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejmech.2013.03.011","volume":"63","author":"Suthar S.K.","year":"2013","unstructured":"Suthar S.K.; Jaiswal V.; Lohan S.; Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: Design, synthesis and biological screening. Eur J Med Chem  2013,63,589-602","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1016\/j.bmc.2014.04.018","volume":"22","author":"Murugesan V.","year":"2014","unstructured":"Murugesan V.; Makwana N.; Suryawanshi R.; Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem  2014,22(12),3159-3170","journal-title":"Bioorg Med Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejmech.2013.08.043","volume":"69","author":"K\u00fc\u00e7\u00fckg\u00fczel I.","year":"2013","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel I.; Sat\u0131lm\u0131\u015f G.; Gurukumar K.R.; 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase. Eur J Med Chem  2013,69,931-941","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/cjoc.201090332","volume":"28","author":"Patel N.B.","year":"2010","unstructured":"Patel N.B.; Patel J.C.; Patel V.N.; Synthesis and antimicrobial activity of quinazolin-4(3H)-ones incorporating sulfonamido-4-thiazolidinone. Chin J Chem  2010,28,1989-1997","journal-title":"Chin J Chem"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s00044-011-9752-8","volume":"21","author":"Desai N.C.","year":"2012","unstructured":"Desai N.C.; Dodiya A.M.; Makwana A.H.; Antimicrobial screening of novel synthesized benzimidazole nucleus containing 4-oxo thiazolidine derivatives. Med Chem Res  2012,21,2320-2328","journal-title":"Med Chem Res"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/jpet.105.084145","volume":"315","author":"Arora A.","year":"2005","unstructured":"Arora A.; Scholar E.M.; Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther  2005,315(3),971-979","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0959-8049(02)80599-8","volume":"38","author":"Manley P.W.","year":"2002","unstructured":"Manley P.W.; Cowan-Jacob S.W.; Buchdunger E.; Imatinib: A selective tyrosine kinase inhibitor. Eur J Cancer  2002,38(Suppl. 5),S19-S27","journal-title":"Eur J Cancer"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1245\/s10434-006-9227-1","volume":"14","author":"Steeghs N.","year":"2007","unstructured":"Steeghs N.; Nortier J.W.; Gelderblom H.; Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: An update of recent developments. Ann Surg Oncol  2007,14(2),942-953","journal-title":"Ann Surg Oncol"},{"key":"ref=31","first-page":"900","volume":"5","author":"Kadam A.M.","year":"2018","unstructured":"Kadam A.M.; MamleDesai SN, Prabhutendulkar C. Synthesis and characterization of quinolin-2-one derivatives as possible cytotoxic agents. European Journal of Biomedical and Pharmaceutical Sciences  2018,5(1),900-905","journal-title":"European Journal of Biomedical and Pharmaceutical Sciences"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.bmc.2014.03.043","volume":"22","author":"Palkar M.B.","year":"2014","unstructured":"Palkar M.B.; Singhai A.S.; Ronad P.M.; Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. Bioorg Med Chem  2014,22(10),2855-2866","journal-title":"Bioorg Med Chem"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods  1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=34","first-page":"1919","volume":"6","author":"Rashad F.M.","year":"2015","unstructured":"Rashad F.M.; Abd El-Nasser N.H.; Dawoud I.F.; Motawe F.H.; Isolation and characterization of antibiotic\/antitumor producing streptomyces. Res J Pharm Biol Chem Sci  2015,6(2),1919","journal-title":"Res J Pharm Biol Chem Sci"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163820666230719110932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218893\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163820666230719110932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T06:13:14Z","timestamp":1714630394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218893\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163820666230719110932","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e190723218893"}}